Go Pro

Sintx Technologies (SINT) Competitors

Sintx Technologies logo
$1.77 +0.07 (+4.12%)
Closing price 04:00 PM Eastern
Extended Trading
$1.65 -0.12 (-6.72%)
As of 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SINT vs. DRTSW, ANZUW, HSCSW, BEATW, and LUCYW

Should you buy Sintx Technologies stock or one of its competitors? MarketBeat compares Sintx Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sintx Technologies include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW).

How does Sintx Technologies compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, Sintx Technologies had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 2 mentions for Sintx Technologies and 1 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 1.14 beat Sintx Technologies' score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sintx Technologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alpha Tau Medical has higher earnings, but lower revenue than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Sintx Technologies$1.02M7.50-$10.36M-$5.07N/A

Sintx Technologies has a consensus price target of $9.33, suggesting a potential upside of 427.31%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Sintx Technologies is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Alpha Tau Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. Alpha Tau Medical's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Sintx Technologies -1,058.60%-366.49%-115.04%

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Sintx Technologies beats Alpha Tau Medical on 7 of the 11 factors compared between the two stocks.

How does Sintx Technologies compare to Anzu Special Acquisition Corp I?

Anzu Special Acquisition Corp I (NASDAQ:ANZUW) and Sintx Technologies (NASDAQ:SINT) are related companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

18.4% of Sintx Technologies shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. Anzu Special Acquisition Corp I's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Anzu Special Acquisition Corp IN/A N/A N/A
Sintx Technologies -1,058.60%-366.49%-115.04%

Anzu Special Acquisition Corp I has higher earnings, but lower revenue than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A
Sintx Technologies$1.02M7.50-$10.36M-$5.07N/A

In the previous week, Sintx Technologies had 2 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 2 mentions for Sintx Technologies and 0 mentions for Anzu Special Acquisition Corp I. Anzu Special Acquisition Corp I's average media sentiment score of 0.00 equaled Sintx Technologies'average media sentiment score.

Company Overall Sentiment
Anzu Special Acquisition Corp I Neutral
Sintx Technologies Neutral

Sintx Technologies has a consensus target price of $9.33, suggesting a potential upside of 427.31%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Sintx Technologies is more favorable than Anzu Special Acquisition Corp I.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anzu Special Acquisition Corp I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Sintx Technologies beats Anzu Special Acquisition Corp I on 7 of the 10 factors compared between the two stocks.

How does Sintx Technologies compare to Heart Test Laboratories?

Heart Test Laboratories (NASDAQ:HSCSW) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Heart Test Laboratories has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. Heart Test Laboratories' return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Heart Test LaboratoriesN/A N/A N/A
Sintx Technologies -1,058.60%-366.49%-115.04%

Heart Test Laboratories has higher earnings, but lower revenue than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart Test Laboratories$4.32KN/AN/AN/AN/A
Sintx Technologies$1.02M7.50-$10.36M-$5.07N/A

In the previous week, Sintx Technologies had 2 more articles in the media than Heart Test Laboratories. MarketBeat recorded 2 mentions for Sintx Technologies and 0 mentions for Heart Test Laboratories. Heart Test Laboratories' average media sentiment score of 0.00 equaled Sintx Technologies'average media sentiment score.

Company Overall Sentiment
Heart Test Laboratories Neutral
Sintx Technologies Neutral

Sintx Technologies has a consensus price target of $9.33, suggesting a potential upside of 427.31%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than Heart Test Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heart Test Laboratories
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

18.4% of Sintx Technologies shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Sintx Technologies beats Heart Test Laboratories on 7 of the 10 factors compared between the two stocks.

How does Sintx Technologies compare to HeartBeam?

Sintx Technologies (NASDAQ:SINT) and HeartBeam (NASDAQ:BEATW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Sintx Technologies presently has a consensus price target of $9.33, suggesting a potential upside of 427.31%. Given Sintx Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe Sintx Technologies is more favorable than HeartBeam.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
HeartBeam
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

HeartBeam has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. HeartBeam's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-1,058.60% -366.49% -115.04%
HeartBeam N/A N/A N/A

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

HeartBeam has lower revenue, but higher earnings than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$1.02M7.50-$10.36M-$5.07N/A
HeartBeamN/AN/AN/AN/AN/A

In the previous week, Sintx Technologies had 2 more articles in the media than HeartBeam. MarketBeat recorded 2 mentions for Sintx Technologies and 0 mentions for HeartBeam. Sintx Technologies' average media sentiment score of 0.00 equaled HeartBeam'saverage media sentiment score.

Company Overall Sentiment
Sintx Technologies Neutral
HeartBeam Neutral

Summary

Sintx Technologies beats HeartBeam on 7 of the 10 factors compared between the two stocks.

How does Sintx Technologies compare to Innovative Eyewear?

Sintx Technologies (NASDAQ:SINT) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Sintx Technologies had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 2 mentions for Sintx Technologies and 0 mentions for Innovative Eyewear. Sintx Technologies' average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score.

Company Overall Sentiment
Sintx Technologies Neutral
Innovative Eyewear Neutral

Sintx Technologies currently has a consensus target price of $9.33, suggesting a potential upside of 427.31%. Given Sintx Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Sintx Technologies is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Innovative Eyewear has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. Innovative Eyewear's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-1,058.60% -366.49% -115.04%
Innovative Eyewear N/A N/A N/A

Innovative Eyewear has higher revenue and earnings than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$1.02M7.50-$10.36M-$5.07N/A
Innovative Eyewear$2.98MN/AN/AN/AN/A

Summary

Sintx Technologies beats Innovative Eyewear on 6 of the 10 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SINT vs. The Competition

MetricSintx TechnologiesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$5.66B$6.86B$12.45B
Dividend YieldN/A1.78%2.60%10.03%
P/E Ratio-0.3523.62280.7224.99
Price / Sales7.5058.67588.0490.94
Price / CashN/A32.5328.6434.82
Price / Book2.216.5011.026.21
Net Income-$10.36M$151.15M$3.48B$347.49M
7 Day Performance14.19%3.29%0.56%0.89%
1 Month Performance-6.84%-1.18%-4.14%-3.60%
1 Year Performance-26.25%5.26%63.23%20.46%

Sintx Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SINT
Sintx Technologies
2.4786 of 5 stars
$1.77
+4.1%
$9.33
+427.3%
-29.2%$0.00$1.02MN/A40
DRTSW
Alpha Tau Medical
N/A$2.55
-14.1%
N/A+1,102.5%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.04
+0.8%
N/A-34.2%$0.00N/AN/A2
HSCSW
Heart Test Laboratories
N/A$0.04
-25.7%
N/A-50.8%$0.00$4.32KN/A10
BEATW
HeartBeam
N/A$0.02
-9.0%
N/A-93.8%$0.00N/AN/A5

Related Companies and Tools


This page (NASDAQ:SINT) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners